Eric Olson

Array ( [id] => 12137032 [patent_doc_number] => 20180015115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-18 [patent_title] => 'RESTORING PHYSIOLOGY WITH SMALL MOLECULE MIMICS OF MISSING PROTEINS' [patent_app_type] => utility [patent_app_number] => 15/520452 [patent_app_country] => US [patent_app_date] => 2015-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12524 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15520452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14196655 [patent_doc_number] => 10265413 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-23 [patent_title] => High molecular weight biodegradable gelatin-doxorubicin conjugate [patent_app_type] => utility [patent_app_number] => 15/524931 [patent_app_country] => US [patent_app_date] => 2015-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 21037 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15524931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14482665 [patent_doc_number] => 10328091 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-25 [patent_title] => Composition comprising Fut2-dependent oligosaccharides and Lacto-N-neotetraose for use in promoting brain development and cognition [patent_app_type] => utility [patent_app_number] => 15/522575 [patent_app_country] => US [patent_app_date] => 2015-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 13751 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15522575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12424884 [patent_doc_number] => 09974799 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-22 [patent_title] => Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof [patent_app_type] => utility [patent_app_number] => 14/926138 [patent_app_country] => US [patent_app_date] => 2015-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 79 [patent_no_of_words] => 47150 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14926138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12022200 [patent_doc_number] => 20170312298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'MIXTURES OF HMOs' [patent_app_type] => utility [patent_app_number] => 15/521582 [patent_app_country] => US [patent_app_date] => 2015-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23128 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15521582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12058674 [patent_doc_number] => 20170335018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-23 [patent_title] => 'PROCESS FOR PRODUCING A CELLULOSE ETHER ACETATE SUCCINATE' [patent_app_type] => utility [patent_app_number] => 15/521028 [patent_app_country] => US [patent_app_date] => 2015-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8429 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15521028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12928549 [patent_doc_number] => 09828633 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-11-28 [patent_title] => Modified nucleotides methods and kits [patent_app_type] => utility [patent_app_number] => 14/883810 [patent_app_country] => US [patent_app_date] => 2015-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 18776 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 240 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14883810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10822022 [patent_doc_number] => 20160168186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'Method of Treating Dengue Fever' [patent_app_type] => utility [patent_app_number] => 14/879463 [patent_app_country] => US [patent_app_date] => 2015-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12260 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14879463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13699729 [patent_doc_number] => 20170360819 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-12-21 [patent_title] => PROCESS FOR PRODUCING A PARTICULATE COMPOSITION COMPRISING AN HYDROUS CRYSTALLINE 2-O-ALPHA-D-GLUCOSYL-L-ASCORBIC ACID [patent_app_type] => utility [patent_app_number] => 14/879280 [patent_app_country] => US [patent_app_date] => 2015-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33705 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14879280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13699729 [patent_doc_number] => 20170360819 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-12-21 [patent_title] => PROCESS FOR PRODUCING A PARTICULATE COMPOSITION COMPRISING AN HYDROUS CRYSTALLINE 2-O-ALPHA-D-GLUCOSYL-L-ASCORBIC ACID [patent_app_type] => utility [patent_app_number] => 14/879280 [patent_app_country] => US [patent_app_date] => 2015-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33705 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14879280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10812186 [patent_doc_number] => 20160158346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'FUCOSYLLACTOSE AS BREAST MILK IDENTICAL NON-DIGESTIBLE OLIGOSACCHARIDE WITH NEW FUNCTIONAL BENEFIT' [patent_app_type] => utility [patent_app_number] => 14/869436 [patent_app_country] => US [patent_app_date] => 2015-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5134 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14869436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14003311 [patent_doc_number] => 10220083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-05 [patent_title] => Vaccines against [patent_app_type] => utility [patent_app_number] => 15/513868 [patent_app_country] => US [patent_app_date] => 2015-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 14 [patent_no_of_words] => 28478 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15513868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14324001 [patent_doc_number] => 10292993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-21 [patent_title] => Method of inhibiting quorum sensing using D-galactose [patent_app_type] => utility [patent_app_number] => 14/860813 [patent_app_country] => US [patent_app_date] => 2015-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 8441 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14860813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11047514 [patent_doc_number] => 20160244472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-25 [patent_title] => 'CRYSTALLINE FORMS OF A MACROLIDE, AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 14/859736 [patent_app_country] => US [patent_app_date] => 2015-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10057 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14859736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11969933 [patent_doc_number] => 20170274087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-28 [patent_title] => 'SACCHARIDE ANALOGS AND AGENTS FOR THE DIAGNOSIS AND THERAPY OF BACTERIAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 15/512696 [patent_app_country] => US [patent_app_date] => 2015-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15946 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15512696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11864748 [patent_doc_number] => 20170232032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-17 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS FOR TREATING EBOLA VIRUS DISEASE' [patent_app_type] => utility [patent_app_number] => 15/514520 [patent_app_country] => US [patent_app_date] => 2015-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18231 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15514520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11908271 [patent_doc_number] => 09777074 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-03 [patent_title] => 'Regioselectively substituted cellulose esters produced in a halogenated ionic liquid process and products produced therefrom' [patent_app_type] => utility [patent_app_number] => 14/858450 [patent_app_country] => US [patent_app_date] => 2015-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 41 [patent_no_of_words] => 42894 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14858450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12192753 [patent_doc_number] => 09896472 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-20 [patent_title] => 'Protected monomer and method of final deprotection for RNA synthesis' [patent_app_type] => utility [patent_app_number] => 14/853790 [patent_app_country] => US [patent_app_date] => 2015-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 36699 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14853790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12049749 [patent_doc_number] => 20170326093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-16 [patent_title] => 'TARGETING K-RAS-MEDIATED SIGNALING PATHWAYS AND MALIGNANCY BY PROSTRATIN' [patent_app_type] => utility [patent_app_number] => 15/508025 [patent_app_country] => US [patent_app_date] => 2015-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 71 [patent_no_of_words] => 21089 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11766894 [patent_doc_number] => 09375408 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-28 [patent_title] => 'Methods of making a deuterated or a non-deuterated molecule and pharmaceutical formulations for treatment' [patent_app_type] => utility [patent_app_number] => 14/841229 [patent_app_country] => US [patent_app_date] => 2015-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 51224 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14841229 [rel_patent_id] =>[rel_patent_doc_number] =>)